GM vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

GM

40.3
AI Score
VS
HIVE Wins

HIVE

65.2
AI Score

Investment Advisor Scores

GM

40score
Recommendation
HOLD

HIVE

65score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GM HIVE Winner
Forward P/E 5.9032 62.8931 GM
PEG Ratio 0.2951 0 Tie
Revenue Growth 2.9% 73.5% HIVE
Earnings Growth 176.3% -99.9% GM
Tradestie Score 40.3/100 65.2/100 HIVE
Profit Margin 2.1% -98.5% GM
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

GM 1M: +5.8% · 3M: +2.9% HIVE 1M: -26.2% · 3M: -32.2%

Current Technical Phase

GM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.4 · Price: $88.90

HIVE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.6%), weak momentum, RSI 36

RSI (14): 35.9 · Price: $1.75

Fundamentals Snapshot

Metric GM HIVE
Market Cap — —
Forward P/E 6.0 -3.4
Trailing P/E 19.4 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.7%
Gross Margin 0.1% 0.4%
Operating Margin 0.1% -0.6%
EPS 4.57 -1.53
Dividend Yield 0.01% —

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.